Skip to main content
. 2022 Jun 9;22:1153. doi: 10.1186/s12889-022-13575-1

Table 2.

Adverse events of special interest (AESIs) and their risk windows.a

No Body system AESI Risk interval (Days after vaccination)
1 Cardiac Acute cardiovascular injury D1-D42
2 Dermatologic Chilblain like lesions D1-D42
3 Dermatologic Single organ cutaneous vasculitis D1-D42
4 Dermatologic Erythema multiforme D1-D42
5 Endocrine Pancreatitis D1-14
6 Endocrine Subacute thyroiditis D1-42
7 Gastrointestinal Acute liver injury D1-D42
8 Hematologic Coagulation disorder (thromboembolism) D1-D42
9 Hematologic Thrombocytopenia D1-D42
10 Immunologic Vaccine-associated enhanced disease Unknown
11

Gastrointestinal

Respiratory

Anosmia, ageusia Unknown
12 Immunologic Anaphylaxis D0-D7
13 Musculoskeletal Acute aseptic arthritis D1-D42
14 Musculoskeletal Rhabdomyolysis D1-D7
15 Neurologic Acute disseminated encephalomyelitis D1-D42
16 Neurologic Bell’s palsy D1-D42
17 Neurologic Generalized convulsion D1-D42
18 Neurologic Guillain-Barré syndrome D1-D42
19 Neurologic Meningoencephalitis D1-D42
20 Renal Acute renal injury D1-D42
21 Respiratory Acute respiratory distress syndrome D1-D42
22 Immunologic

Multisystem inflammatory syndrome in

children [Only for under 18 Y/O subgroup]

D1-D42

aAdapted from WHO template (Reference No. [13])